According to the World Health Organization and ClinicalTrials.gov, there are currently 1,114 ongoing clinical studies of treatments for COVID-19. A GlobalData analysis indicates that so far, 21 of the trials have reported interim results, and out of them, 16 showed positive early results.
Two of those studies are for Gilead Sciences’ remdesivir, which has since been granted emergency use authorization by the U.S. Food and Drug Administration (FDA).
